CompletedNot Applicable

Effectiveness and Safety of YVOIRE Y-Solution 540

China394 participantsStarted 2021-07-01

Plain-language summary

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 versus YVOIRE volume plus in Nasolabial Folds Injection

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 3 (moderate) or 4 (severe) on the 5-graded WSRS * who sign the written informed consent form Exclusion Criteria: * who have received permanent facial implants * who have received semi-permanent fillers * who have undergone temporary dermal filler treatment within 12 months * who have undergone facial tissue augmentation with fat injections, botulinum toxin injections, mesotherapy, or cosmetic procedures within 6 months * who have a history of anaphylaxis or allergy to lidocaine, hyaluronic acid (HA) products, or streptococcal protein

What they're measuring

WSRS responder rate

Timeframe: 24 weeks after the last injection

Trial details

NCT IDNCT04855188

SponsorLG Chem

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-09-29

View on ClinicalTrials.gov More Wrinkles in the Nasolabial Folds trials